PPB - Services

Complaints, Feedback and Enquiry

Medicine Quality Alert: Class II Medicine Recall of Medopress (Methyldopa 250mg) Tablets Batch No. 221137, 230051, 230093, and 230165

The Pharmacy and Poisons Board has mandated Cosmos Ltd to initiate an urgent recall of medopress (methyldopa 250mg) tablets Batch no. 221137, 230051, 230093, and 230165 manufactured by Cosmos Ltd, Kenya.

From: Pharmacy and Poisons Board

Date initiated: 3rd April 2025

Recall Reference Number: REC/2025/011

Recall Classification: Class II

Recall Level: Retail/Facility level

Manufacturer: Cosmos Ltd, Kenya

Product name: Medopress

Active Pharmaceutical Ingredient: Methyldopa 250mg

Affected counties: All

Affected Batch

Batch Number

Date of Manufacture

Date of expiry

Pack Size

230093

11/2023

10/2026

10×10

230051

05/2023

04/2026

10×10

221137

03/2023

02/2026

10×10

230165.

03/2023

02/2026

10×10

Brief description of the problem

The product is being recalled due to color change of the tablets.

Action for healthcare professionals

Quarantine all remaining stock and stop further distribution, sale, issuing or use of the above batches immediately. Await contact from Cosmos Ltd to arrange the return.

Action for patients and caregivers

No further action is required by patients as this is a Retail/hospital Pharmacy and Wholesaler/Distributor level recall. You are advised to talk to your healthcare professional if you have the above batches of medopress (methyldopa 250mg) tablets

Further Information

For inquiries about consignments of the impacted batch, please contact Cosmos Ltd at: lina.lakhani@cosmos-pharm.com, info@cosmos-pharm.com or by Telephone at: + 254 (0) 709 864 000, + 254 (0) 722 333 834, + 254 (0) 733 666 834

You are advised to promptly report any case(s) of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:

For any further enquiries and feedback on the product recall, contact the post-marketing surveillance unit at the Pharmacy and Poisons Board via email at pms@ppb.go.ke

Download document

Medicine Quality Alert: Class II Medicine Recall of Medopress (Methyldopa 250mg) Tablets Batch No. 221137, 230051, 230093, and 230165